Interactions between oxaprozin glucuronide and human serum albumin

References

• Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 1976; 72: 248–254
   PubMed Web of Science ®Google Scholar
• Compernolle F., Blankaert N., Heirwegh K. The fate of bilirubin-IXα glucuronides in cholestatic bile: sequential migration of the 1-acylaglycone to the 2-, 3- and 4-positions of glucuronic acid. Biochemical Society Transactions 1977; 5: 317–319
   PubMed Web of Science ®Google Scholar
• Cunningham V. J., Hay L., Stoner H. B. The binding of L-tryptophan to serum albumins in the presence of non-esterified fatty acids. Biochemical Journal 1975; 146: 653–658
   PubMed Web of Science ®Google Scholar
• Dickinson R. G., Hooper W. D., Eadie M. J. pH-Dependent rearrangement of the biosynthetic ester glucuronide of valproic acid to β-glucuronidase-resistant forms. Drug Metabolism and Disposition 1984; 12: 247–252
   PubMed Web of Science ®Google Scholar
• Eggers N. J., Doust K. Isolation and identification of probenecid acyl glucuronide. Journal of Pharmacy and Pharmacology 1981; 33: 123–124
   PubMed Web of Science ®Google Scholar
• Ellman G. L. Tissue sulfhydryl groups. Archives of Biochemistry and Biophysics 1959; 82: 70–77
   PubMed Web of Science ®Google Scholar
• Faed E. M. Properties of acyl glucuronides: implications for studies of the pharmacokinetics and metabolism of acidic drugs. Drug Metabolism Reviews 1984; 15: 1213–1249
   PubMed Web of Science ®Google Scholar
• Faed E. M., Mcqueen E. G. Separation of two conjugates of clofibric acid (CPIB) found in the urine of subjects taking clofibrate. Clinical and Experimental Pharmacology and Physiology 1978; 5: 195–198
   PubMed Web of Science ®Google Scholar
• Faed E. M., Mcqueen E. G. Plasma half-life of clofibric acid in renal failure. British Journal of Clinical Pharmacology 1979; 7: 407–410
   PubMed Web of Science ®Google Scholar
• Fehske K. J., Muller W. E., Wollert U. A highly reactive tyrosine residue as part of the indole and benzodiazepine binding site of human serum albumin. Biochimica et Biophysica Acta 1979; 577: 346–359
   PubMedGoogle Scholar
• Fehske K. J., Muller W. E., Wollert U. Direct demonstration of the highly reactive tyrosine residue of human serum albumin located in fragment 299–585. Archives of Biochemistry and Biophysics 1980; 205: 217–221
   PubMed Web of Science ®Google Scholar
• Fehske K. J., Muller W. E., Schlafer U., Wollert U. Characterisation of two important drug binding sites on human serum albumin. Progress in Drug Protein Binding. Proc. Lect. Symp. 2nd 1981; 5–15
   Google Scholar
• Gautam A., Seligson H., Gordon E. R., Seligson D., Boyer J. L. Irreversible binding of conjugated bilirubin to albumin in cholestatic rats. Journal of Clinical Investigation 1984; 73: 873–877
   PubMed Web of Science ®Google Scholar
• Gregory J. D. The stability of n-ethylmaleimide and its reaction with sulfhydryl groups. Journal of the American Chemical Society 1955; 77: 3922–3923
   Web of Science ®Google Scholar
• Gugler R. The effect of disease on the response to drugs. Proceedings of the 7th International Congress of Pharmacology, P. Duchene-Mairwaz. Pergamon Press, Oxford 1979
   Google Scholar
• Hasegawa J., Smith P. C., Benet L. Z. Apparent intramolecular acyl migrations of zomepirac glucuronide. Drug Metabolism and Disposition 1982; 10: 469–473
   PubMed Web of Science ®Google Scholar
• Hughes W. L., Saroff H. A., Carney A. L. Preparation and properties of serum and plasma proteins. XXII. A crystallizable guanidinated derivative of human serum albumin. Journal of the American Chemical Society 1949; 71: 2476–2480
   Web of Science ®Google Scholar
• Illing H. P., Wilson I. D. PH dependent formation of β-glucuronidase resistant conjugates from the biosynthetic ester glucuronide of isoxepac. Biochemical Pharmacology 1981; 30: 3381–3384
   PubMed Web of Science ®Google Scholar
• Jacobsen C., Jacobsen J. Dansylation of human serum albumin in the study of the primary binding sites of bilirubin and L-tryptophan. Biochemical Journal 1979; 181: 251–253
   PubMed Web of Science ®Google Scholar
• Janssen F. W., Chiang S. T., Walker B. R., Ruelius H. W. Disposition of oxaprozin in healthy subjects and certain disease states. Current Therapeutic Research 1984; 35: 363–376
   Web of Science ®Google Scholar
• Janssen F. W., Kirkman S. K., Fenselau C., Stogniew M., Hofmann B. R., Young E. M., Ruelius H. W. Metabolic formation of N- and O-glucuronides of 3-(p-chlorophenyl)thiazolo[3,2-a]benzimidazoie-2-acetic acid. Rearrangement of the 1-O-acyl glucuronide. Drug Metabolism and Disposition 1982; 10: 599–604
   PubMed Web of Science ®Google Scholar
• Kurono Y., Maki T., Yatsuyanagi T., Ikeda K. Esterase-like activity of human serum albumin: structure-activity relationships for the reactions with phenyl acetates and p-nitrophenyl esters. Chemical and Pharmaceutical Bulletin 1979; 27: 2781–2786
   PubMed Web of Science ®Google Scholar
• Lauff J. J., Kasper M. E., Wu T. W., Ambrose R. T. Isolation and preliminary characterization of a fraction of bilirubin in serum that is firmly bound to protein. Clinical Chemistry 1982; 28: 629–637
   PubMed Web of Science ®Google Scholar
• Lewis A. J., Carlson R. P., Chang J., Gilman S. C., Nielsen S., Rosenthale M. E., Janssen F. W., Ruelius H. W. The pharmacological profile of oxaprozin, an antiinflammatory and analgesic agent with low gastrointestinal toxicity. Current Therapeutic Research 1983; 34: 777–794
   Web of Science ®Google Scholar
• Lundblad R. L., Noyes C. M. Chemical Reagents for Protein Modification. CRC Press, Boca Raton 1984; Vol I: 55, 127
   Google Scholar
• Mcdonagh A. F., Palma L. A., Lauff J. J., Wu J. W. Origin of mammalian biliprotein and rearrangement of bilirubin glucuronides in vivo in the rat. Journal of Clinical Investigation 1984; 74: 763–769
   PubMed Web of Science ®Google Scholar
• Means G. E., Bender M. L. Acetylation of human serum albumin by p-nitrophenyl acetate. Biochemistry 1975; 14: 4989–4994
   PubMed Web of Science ®Google Scholar
• Means G. E., Wu H. L. The reactive tyrosine residue of human serum albumin; characterization of its reaction with diisopropylfluorophosphate. Archives of Biochemistry and Biophysics 1979; 194: 526–530
   PubMed Web of Science ®Google Scholar
• Muller W. E., Wollert U. High stereospecificity of the benzodiazepine binding site on human serum albumin. Studies with d- and l-oxazepam hemisuccinate. Molecular Pharmacology 1975; 11: 52–60
   PubMed Web of Science ®Google Scholar
• Musson D. G., Lin J. H., Lyon C., Tocco D. J., Yeh K. C. Assay methodology for quantification of the ester and ether glucuronide conjugates of diflunisal in human urine. Journal of Chromatography 1985; 337: 363–378
   PubMed Web of Science ®Google Scholar
• Ohta N., Kurono Y., Ikeda K. Esterase-like activity of human serum albumin II: reaction with N-trans-cinnamoylimidazoles. Journal of Pharmaceutical Science 1983; 72: 385–388
   PubMed Web of Science ®Google Scholar
• Rachmel A., Hazelton G. A., Yergey A. L., Liberato D. J. Furosemide 1-O-acyl glucuronide. In vitro biosynthesis and pH-dependent isomerization to β-glucuronidase-resistant forms. Drug Metabolism and Disposition 1985; 13: 705–710
   PubMed Web of Science ®Google Scholar
• Ruelius H. W., Kirkman S. K., Young E. M., Janssen F. W. Reactions of oxaprozin-1-O-acyl glucuronide in solutions of human plasma and albumin. Biological Reactive Intermediates III, J. J. Kocsis, D. J. Jollow, C. M. Witmer, J. O. Nelson, R. Snyder. Plenum Press, New York 1986, In press
   Google Scholar
• Ruelius H. W., Young E. M., Kirkman S. K., Schillings R. T., Sisenwine S. F., Janssen F. W. Biological fate of acyl glucuronides in the rat. The role of rearrangement, intestinal enzymes and reabsorption. Biochemical Pharmacology 1985; 34: 451–452
   Web of Science ®Google Scholar
• Sinclair K. A., Caldwell J. The formation of β-glucuronidase resistant glucuronides by the intramolecular rearrangement of glucuronic acid conjugates at mild alkaline pH. Biochemical Pharmacology 1982; 31: 953–957
   PubMed Web of Science ®Google Scholar
• Sjöholm I., Ekman B., Kober A., Ljungstedt-Pahlman I., Seiving B., Sjodin T. Binding of drugs to human serum albumin: XI. The specificity of three binding sites as studied with albumin immobilized in microparticles. Molecular Pharmacology 1979; 16: 767–777
   PubMed Web of Science ®Google Scholar
• Smith P. C., Mcdonaugh A. F., Benet L. Z. Irreversible binding of zomepirac to plasma protein in vitro and in vivo. Journal of Clinical Investigation 1986; 77: 934–939
   PubMed Web of Science ®Google Scholar
• Sokolovsky M., Riordan J. F., Vallee B. L. Tetranitromethane. A reagent for the nitration of tyrosyl residues in proteins. Biochemistry 1966; 5: 3582–3589
   PubMed Web of Science ®Google Scholar
• Sudlow G., Birkett D. J., Wade D. N. Further characterization of specific drug binding sites on human serum albumin. Molecular Pharmacology 1976; 12: 1052–1061
   PubMed Web of Science ®Google Scholar
• Van Breemen R. B., Fenselau C. Acylation of albumin by 1-O-acyl glucuronides. Drug Metabolism and Disposition 1985; 13: 318–320
   PubMed Web of Science ®Google Scholar
• Walker J. E. Lysine residue 199 of human serum albumin is modified by acetylsalicylic acid. FEBS Letters 1976; 66: 173–175
   PubMed Web of Science ®Google Scholar
• Weber C. J. A modification of Sakaguchi's reaction for the quantitative determination of arginine. Journal of Biological Chemistry 1930; 86: 217–222
   Google Scholar